Pfizer exits Chinese generic drugs JV, Hisun-Pfizer Pharmaceuticals

Pfizer exits Chinese generic drugs JV, Hisun-Pfizer Pharmaceuticals

In a significant shift within the pharmaceutical industry, Pfizer Inc. has announced its decision to exit the Hisun-Pfizer Pharmaceuticals joint venture by divesting its 49% stake to Sapphire I (HK) Holdings. The deal, for which the terms were not disclosed, marks the end of Pfizer’s involvement in the Chinese generic drugs market through this joint […]